Aurobindo Pharma may touch Rs 400: Sudarshan Sukhani

Sudarshan Sukhani of s2analytics.com told CNBC-TV18, " Aurobindo Pharma 's eventual target is Rs 400 plus, which means that when Auro Pharma is in a consolidation, in some kind of minor correction one will want to buy it as a position trader. It is not a short-term instrument that lends itself to short-term trading but at Rs 270 one may look at 50 percent gain in the next one year."

At 14:08 hrs Aurobindo Pharma was quoting at Rs 279.25, up Rs 5.95, or 2.18 percent. It has touched a 52-week high of Rs 280.70.

The share touched its 52-week high Rs 277.80 and 52-week low Rs 147 on 13 November, 2013 and 28 March, 2013, respectively. Currently, it is trading 0.52 percent below its 52-week high and 89.97 percent above its 52-week low. Market capitalisation stands at Rs 8,132.08 crore.

Anda sedang membaca artikel tentang

Aurobindo Pharma may touch Rs 400: Sudarshan Sukhani

Dengan url

http://sehatgayahidup.blogspot.com/2013/11/aurobindo-pharma-may-touch-rs-400.html

Anda boleh menyebar luaskannya atau mengcopy paste-nya

Aurobindo Pharma may touch Rs 400: Sudarshan Sukhani

namun jangan lupa untuk meletakkan link

Aurobindo Pharma may touch Rs 400: Sudarshan Sukhani

sebagai sumbernya